f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", |
| "groups": [], | | "groups": [], |
| "id": "ce944169-9658-4f7f-a16d-876bd5c768f1", | | "id": "ce944169-9658-4f7f-a16d-876bd5c768f1", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2023-02-07T07:28:00.620909", | | "metadata_created": "2023-02-07T07:28:00.620909", |
n | "metadata_modified": "2023-02-07T07:28:43.973575", | n | "metadata_modified": "2023-02-07T07:31:44.482717", |
| "name": "malawi-integrated-hiv-program-report-2021-q3", | | "name": "malawi-integrated-hiv-program-report-2021-q3", |
| "notes": "__Program performance highlights by the end of September | | "notes": "__Program performance highlights by the end of September |
| 2021 include:__\r\n\r\n* Scale-up of integrated HIV services had | | 2021 include:__\r\n\r\n* Scale-up of integrated HIV services had |
t | reached the following number of sites:\r\n * __760__ static | t | reached the following number of sites:\r\n * __760__ |
| and __160__ outreach HIV testing sites.\r\n * __767__ | | static and __160__ outreach HIV testing sites.\r\n * |
| (static) ART sites; __612__ of these started at least one pregnant or | | __767__ (static) ART sites; __612__ of these started at least one |
| breastfeeding woman.\r\n * __706__ sites with HIV-exposed | | pregnant or breastfeeding woman.\r\n * __706__ sites with |
| children in follow-up.\r\n* __642,325__ persons were tested for HIV by | | HIV-exposed children in follow-up.\r\n* __642,325__ persons were |
| a trained provider and received their results; __115,831 (18%)__ | | tested for HIV by a trained provider and received their results; |
| accessed HIV testing for the first time; __526,492 (82%)__ were repeat | | __115,831 (18%)__ accessed HIV testing for the first time; __526,492 |
| testers and __20,665 (4%)__ of these received confirmatory testing | | (82%)__ were repeat testers and __20,665 (4%)__ of these received |
| (after having tested positive in the past). __18,568 (3.0%)__ clients | | confirmatory testing (after having tested positive in the past). |
| received a positive result for the first time.\r\n* A total of | | __18,568 (3.0%)__ clients received a positive result for the first |
| __142,158__ people received __235,133__ self-test kits; __110,183 | | time.\r\n* A total of __142,158__ people received __235,133__ |
| (45%)__ of these were for use by the recipient and __124,950 (55%)__ | | self-test kits; __110,183 (45%)__ of these were for use by the |
| for onward distribution to sex partners or other people.\r\n* __22,397 | | recipient and __124,950 (55%)__ for onward distribution to sex |
| (98%)__ of __22,902__ blood units collected were screened for (at | | partners or other people.\r\n* __22,397 (98%)__ of __22,902__ blood |
| least) HIV, hepatitis B and syphilis.\r\n* A cumulative total of | | units collected were screened for (at least) HIV, hepatitis B and |
| __5,905__ clients were referred for PrEP eligibility screening and | | syphilis.\r\n* A cumulative total of __5,905__ clients were referred |
| __5,579 (94%)__ were found eligible. __4,750 (85%)__ were enrolled to | | for PrEP eligibility screening and __5,579 (94%)__ were found |
| on PrEP and __3,839 (81%)__ clients were retained on PrEP at the end | | eligible. __4,750 (85%)__ were enrolled to on PrEP and __3,839 (81%)__ |
| of the September 2021.\r\n* __156,552 (96%)__ of __163,446__ women at | | clients were retained on PrEP at the end of the September 2021.\r\n* |
| ANC had their HIV status ascertained; __8,885 (6%)__ of these were HIV | | __156,552 (96%)__ of __163,446__ women at ANC had their HIV status |
| positive. __137,258 (95%)__ of __145,024__ at maternity had their HIV | | |
| status ascertained __8,713 (6%)__ of these were HIV positive.\r\n* | | ascertained; __8,885 (6%)__ of these were HIV positive. __137,258 |
| __18,792__ patients started ART this quarter; __87%__ were classified | | (95%)__ of __145,024__ at maternity had their HIV status ascertained |
| as asymptomatic / in WHO stage 1 and started under the \u201cTest & | | __8,713 (6%)__ of these were HIV positive.\r\n* __18,792__ patients |
| | | started ART this quarter; __87%__ were classified as asymptomatic / in |
| | | WHO stage 1 and started under the \u201cTest & Treat\u201d |
| Treat\u201d policy.\r\n* __887,338__ patients were alive and on ART by | | policy.\r\n* __887,338__ patients were alive and on ART by end of |
| end of September 2021. This means that __90%__ of the estimated | | September 2021. This means that __90%__ of the estimated __986,654__ |
| __986,654__ HIV positive population was on ART. ART coverage was | | HIV positive population was on ART. ART coverage was __79% (45,504/ |
| __79% (45,504/ 54,686)__ for children and __89% (844,834 / 931,968)__ | | 54,686)__ for children and __89% (844,834 / 931,968)__ for |
| for adults.\r\n* __95,002 (93%)__ of viral load results from routine | | adults.\r\n* __95,002 (93%)__ of viral load results from routine |
| monitoring were <1000 copies/ml. Viral suppression rates for routine | | monitoring were <1000 copies/ml. Viral suppression rates for routine |
| samples among children (0-14 years) and adults (15+ years) were | | samples among children (0-14 years) and adults (15+ years) were |
| __73%__ and __93%__, respectively.\r\n* __79%__ of adults and __81%__ | | __73%__ and __93%__, respectively.\r\n* __79%__ of adults and __81%__ |
| of children were retained alive on ART at 12 months after | | of children were retained alive on ART at 12 months after |
| initiation.\r\n* Out of __874,993__ patients on first line adult ART | | initiation.\r\n* Out of __874,993__ patients on first line adult ART |
| __840,657 (97%)__ had transitioned to TDF/3TC/DTG and only __2,450 | | __840,657 (97%)__ had transitioned to TDF/3TC/DTG and only __2,450 |
| (<1%)__ were on TDF/3TC/EFV.\r\n* __9,385 6 (99%)__ of an estimated | | (<1%)__ were on TDF/3TC/EFV.\r\n* __9,385 6 (99%)__ of an estimated |
| __9,5513__ HIV infected pregnant women in Malawi were on ART this | | __9,5513__ HIV infected pregnant women in Malawi were on ART this |
| quarter. __6,751 (71%)__ of these were already on ART when getting | | quarter. __6,751 (71%)__ of these were already on ART when getting |
| pregnant and __2,634 (29%)__ started ART during | | pregnant and __2,634 (29%)__ started ART during |
| pregnancy/delivery.\r\n* An additional __722__ breastfeeding women | | pregnancy/delivery.\r\n* An additional __722__ breastfeeding women |
| (re-)started ART in WHO stage 1 or 2.", | | (re-)started ART in WHO stage 1 or 2.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 9, | | "num_tags": 9, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2023-02-07T07:28:41.505158", | | "created": "2023-02-07T07:28:41.505158", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "cefc0a53-ce51-44d4-b958-9c763868be6d", | | "id": "cefc0a53-ce51-44d4-b958-9c763868be6d", |
| "last_modified": "2023-02-07T07:28:41.455660", | | "last_modified": "2023-02-07T07:28:41.455660", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2021-q3", | | "dha/malawi-integrated-hiv-program-report-2021-q3", |
| "metadata_modified": "2023-02-07T07:28:43.979577", | | "metadata_modified": "2023-02-07T07:28:43.979577", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "Malawi Integrated HIV Program Report 2021 Q3", | | "name": "Malawi Integrated HIV Program Report 2021 Q3", |
| "package_id": "ce944169-9658-4f7f-a16d-876bd5c768f1", | | "package_id": "ce944169-9658-4f7f-a16d-876bd5c768f1", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "efbb04a0049920bf84b418fe85d3dc43e29f4de252505894ac2f6562b27a8748", | | "efbb04a0049920bf84b418fe85d3dc43e29f4de252505894ac2f6562b27a8748", |
| "size": 4247307, | | "size": 4247307, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 763868be6d/download/malawi_integrated_hiv_program_report_2021-q3.pdf", | | 763868be6d/download/malawi_integrated_hiv_program_report_2021-q3.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "HTC", | | "display_name": "HTC", |
| "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", |
| "name": "HTC", | | "name": "HTC", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "PMTCT-ART", | | "display_name": "PMTCT-ART", |
| "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", |
| "name": "PMTCT-ART", | | "name": "PMTCT-ART", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "anc", | | "display_name": "anc", |
| "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", |
| "name": "anc", | | "name": "anc", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "blood safety", | | "display_name": "blood safety", |
| "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", |
| "name": "blood safety", | | "name": "blood safety", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "hiv", | | "display_name": "hiv", |
| "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", |
| "name": "hiv", | | "name": "hiv", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "maternity", | | "display_name": "maternity", |
| "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", |
| "name": "maternity", | | "name": "maternity", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "report", | | "display_name": "report", |
| "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", |
| "name": "report", | | "name": "report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "sti", | | "display_name": "sti", |
| "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", |
| "name": "sti", | | "name": "sti", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "viral load", | | "display_name": "viral load", |
| "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", |
| "name": "viral load", | | "name": "viral load", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2021 Q3", | | "title": "Malawi Integrated HIV Program Report 2021 Q3", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2021" | | "year": "2021" |
| } | | } |